NYSE - Delayed Quote USD

Perrigo Company plc (PRGO)

31.23 +0.74 (+2.43%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,655,600.00
4,655,600.00
4,451,600.00
4,138,700.00
4,088,200.00
Cost of Revenue
2,975,200.00
2,975,200.00
2,996,200.00
2,722,500.00
2,593,300.00
Gross Profit
1,680,400.00
1,680,400.00
1,455,400.00
1,416,200.00
1,494,900.00
Operating Expense
1,396,300.00
1,396,300.00
1,334,000.00
815,800.00
1,226,500.00
Operating Income
284,100.00
284,100.00
121,400.00
600,400.00
268,400.00
Net Non Operating Interest Income Expense
-173,800.00
-173,800.00
-156,000.00
-125,000.00
-127,700.00
Other Income Expense
-118,600.00
-118,600.00
-104,500.00
-216,700.00
-134,800.00
Pretax Income
-8,300.00
-8,300.00
-139,100.00
258,700.00
5,900.00
Tax Provision
-3,900.00
-3,900.00
-8,200.00
389,600.00
-38,300.00
Net Income Common Stockholders
-12,700.00
-12,700.00
-140,600.00
-68,900.00
-162,600.00
Diluted NI Available to Com Stockholders
-12,700.00
-12,700.00
-140,600.00
-68,900.00
-162,600.00
Basic EPS
-0.09
--
-1.04
-0.52
-1.20
Diluted EPS
-0.09
--
-1.04
-0.52
-1.20
Basic Average Shares
135,300.00
--
134,500.00
133,600.00
136,100.00
Diluted Average Shares
135,300.00
--
134,500.00
133,600.00
137,200.00
Total Operating Income as Reported
151,900.00
151,900.00
78,900.00
410,400.00
265,200.00
Total Expenses
4,371,500.00
4,371,500.00
4,330,200.00
3,538,300.00
3,819,800.00
Net Income from Continuing & Discontinued Operation
-12,700.00
-12,700.00
-140,600.00
-68,900.00
-162,600.00
Normalized Income
97,510.00
97,510.00
-82,532.60
7,800.00
130,705.00
Interest Expense
173,800.00
173,800.00
156,000.00
125,000.00
127,700.00
Net Interest Income
-173,800.00
-173,800.00
-156,000.00
-125,000.00
-127,700.00
EBIT
165,500.00
165,500.00
16,900.00
383,700.00
133,600.00
EBITDA
525,000.00
525,000.00
355,500.00
695,900.00
518,400.00
Reconciled Cost of Revenue
2,975,200.00
2,975,200.00
2,996,200.00
2,722,500.00
2,593,300.00
Reconciled Depreciation
359,500.00
359,500.00
338,600.00
312,200.00
384,800.00
Net Income from Continuing Operation Net Minority Interest
-4,400.00
-4,400.00
-130,900.00
-130,900.00
44,200.00
Total Unusual Items Excluding Goodwill
-129,000.00
-129,000.00
-51,400.00
-190,000.00
-118,500.00
Total Unusual Items
-129,000.00
-129,000.00
-51,400.00
-190,000.00
-118,500.00
Normalized EBITDA
654,000.00
654,000.00
406,900.00
885,900.00
636,900.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-27,090.00
-27,090.00
-3,032.60
-51,300.00
-31,995.00
12/31/2020 - 12/17/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TAK Takeda Pharmaceutical Company Limited
13.23
-1.12%
 
TEVA Teva Pharmaceutical Industries Limited
13.01
0.00%
 
HLN Haleon plc
8.35
-0.71%
 
CTLT Catalent, Inc.
55.95
-0.14%
 
KMDA Kamada Ltd.
5.18
+1.57%
 
VTRS Viatris Inc.
11.55
+1.67%
 
EBS Emergent BioSolutions Inc.
2.1800
-4.80%
 
ALKS Alkermes plc
24.65
+1.61%
 
INDV Indivior PLC
18.81
+0.97%
 
PETQ PetIQ, Inc.
16.53
-0.42%